Seer Q2 revenue $4.1M (+32% YoY); launches Proteograph ONE & SP200

Seer, Inc.

Revenue of $4.1M for Q2 2025, up 32% from $3.1M a year ago, driven by product and service revenue.
Net loss narrowed to $19.4M from $22.9M; operating expenses down 21% to $22.6M.
Cash, equivalents and investments of $263.3M as of June 30, 2025.
Full-year 2025 revenue guidance reaffirmed at $17M-$18M (24% midpoint growth).
Launched high-throughput Proteograph ONE assay and SP200 automation instrument.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.